XENE · Xenon Pharmaceuticals Inc
United States · RS rating 28 · As of 2026-11-03
| Price | 38.23 USD |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 63 / 13 / 44 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 9 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -13.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +46.1% |
| Market cap (USD) | $5.4B |